DD140047A5 - Verfahren zur herstellung racemischer und optisch aktiver halbprostanoid-glycoside und-thioglycoside - Google Patents

Verfahren zur herstellung racemischer und optisch aktiver halbprostanoid-glycoside und-thioglycoside Download PDF

Info

Publication number
DD140047A5
DD140047A5 DD78208071A DD20807178A DD140047A5 DD 140047 A5 DD140047 A5 DD 140047A5 DD 78208071 A DD78208071 A DD 78208071A DD 20807178 A DD20807178 A DD 20807178A DD 140047 A5 DD140047 A5 DD 140047A5
Authority
DD
German Democratic Republic
Prior art keywords
general formula
compounds
group
meaning
hydroxy
Prior art date
Application number
DD78208071A
Other languages
German (de)
English (en)
Inventor
Tibor Szabo
Laszlo Institoris
Gabor Kovacs
Gyula Dalmadi
Bela Koeszegi
Istvan Stadler
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of DD140047A5 publication Critical patent/DD140047A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
DD78208071A 1977-09-26 1978-09-25 Verfahren zur herstellung racemischer und optisch aktiver halbprostanoid-glycoside und-thioglycoside DD140047A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU77CI1771A HU178202B (en) 1977-09-26 1977-09-26 Process for preparing new,optically active and racemic bicyclic acetals and merkaptals

Publications (1)

Publication Number Publication Date
DD140047A5 true DD140047A5 (de) 1980-02-06

Family

ID=10994671

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78208071A DD140047A5 (de) 1977-09-26 1978-09-25 Verfahren zur herstellung racemischer und optisch aktiver halbprostanoid-glycoside und-thioglycoside

Country Status (21)

Country Link
US (1) US4257962A (nl)
JP (1) JPS5459267A (nl)
AT (1) AT369363B (nl)
BE (1) BE870759A (nl)
CA (1) CA1191845A (nl)
CH (1) CH644373A5 (nl)
CS (1) CS209504B2 (nl)
DD (1) DD140047A5 (nl)
DE (1) DE2841181A1 (nl)
DK (1) DK424578A (nl)
FI (1) FI69460C (nl)
FR (1) FR2404004A1 (nl)
GB (1) GB2005677B (nl)
GR (1) GR65212B (nl)
HU (1) HU178202B (nl)
IL (1) IL55576A (nl)
IT (1) IT1160676B (nl)
NL (1) NL7809735A (nl)
PL (1) PL115376B1 (nl)
SE (1) SE443979B (nl)
SU (1) SU890973A3 (nl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4499292A (en) * 1983-05-13 1985-02-12 E. R. Squibb & Sons, Inc. 7-Oxabicycloheptane prostaglandin intermediates and method for preparing same
CN106349138A (zh) * 2011-06-02 2017-01-25 奇诺因私人有限公司 用于制备前列腺素酰胺的新的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3023183A (en) * 1959-06-29 1962-02-27 Cuban American Sugar Company Esterification
US3657328A (en) * 1970-05-22 1972-04-18 Ciba Geigy Corp Pge1 oximes
BE795199A (fr) * 1972-05-10 1973-08-09 Ciba Geigy Nouveaux oxabicyclononanes et leurs procedes de preparation
US3975406A (en) * 1972-07-06 1976-08-17 Hans Johann Mayer Hexahydro-5-oxy-2-loweralkoxy-2H-cyclopenta[b]-furan-4-carbonitrile intermediates for prostaglandins
US3987085A (en) * 1972-09-15 1976-10-19 The Upjohn Company 8β,11β,12α-PGF2.sub.α compounds
US4036871A (en) * 1973-08-06 1977-07-19 Hoffmann-La Roche Inc. 11-Substituted prostaglandins
US4041064A (en) * 1974-09-17 1977-08-09 Carlo-Erba S.P.A. 16-Methyl prost-5-en-13-ynoic acid derivatives
US4064351A (en) * 1974-09-19 1977-12-20 Sankyo Company Limited 9-OXO-15 ξ-HYDROXY-20-ALKYLIDENEPROST-13(TRANS)-ENOIC ACID DERIVATIVES
US4094886A (en) * 1976-03-01 1978-06-13 (Zaidanhojin) Sagami Chemical Research Center Process for producing allyl alcohol derivatives useful in prostaglandin synthesis
JPS5398953A (en) * 1977-02-08 1978-08-29 Ono Pharmaceut Co Ltd Prostaglandin x analogues and process for their preparation

Also Published As

Publication number Publication date
JPS5459267A (en) 1979-05-12
BE870759A (fr) 1979-01-15
FI69460C (fi) 1986-02-10
GB2005677A (en) 1979-04-25
IT7869212A0 (it) 1978-09-26
IL55576A (en) 1982-03-31
IT1160676B (it) 1987-03-11
FI69460B (fi) 1985-10-31
CS209504B2 (en) 1981-12-31
FI782913A (fi) 1979-03-27
CA1191845A (en) 1985-08-13
ATA692578A (de) 1982-05-15
FR2404004A1 (fr) 1979-04-20
GB2005677B (en) 1982-05-26
SU890973A3 (ru) 1981-12-15
DE2841181A1 (de) 1979-04-05
NL7809735A (nl) 1979-03-28
AT369363B (de) 1982-12-27
FR2404004B1 (nl) 1982-12-17
DK424578A (da) 1979-03-27
HU178202B (en) 1982-03-28
SE7809947L (sv) 1979-03-27
US4257962A (en) 1981-03-24
CH644373A5 (de) 1984-07-31
PL209858A1 (pl) 1979-09-10
PL115376B1 (en) 1981-03-31
SE443979B (sv) 1986-03-17
IL55576A0 (en) 1978-12-17
GR65212B (en) 1980-07-30

Similar Documents

Publication Publication Date Title
DE69923768T2 (de) Cephalotoxanderivative und verfahren zu ihrer herstellung
CH632506A5 (de) Verfahren zur herstellung eines optischen isomers eines 1-hydroxy-3-substituierten-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9h-dibenzo(b,d)pyran-9-ons.
DE2858726C2 (de) Arzneimittel zur senkung des serumcholesterinspiegels
DE2750812C2 (de) 4-Alkoxy-4-desmethoxydaunomycine und Verfahren zu deren Herstellung
DE1543891A1 (de) Ein neues Glucosid sowie ein Verfahren zu seiner Herstellung
EP0237902A2 (de) Verfahren zur Herstellung des (-)-Antipoden des (E)-1-Cyclohexyl-4,4-dimethyl-3-hydroxy-2-(1,2,4-triazol-1-yl)-pent-1-ens
CH617440A5 (nl)
DD140047A5 (de) Verfahren zur herstellung racemischer und optisch aktiver halbprostanoid-glycoside und-thioglycoside
EP0137309B1 (de) Mehrcyclische Kohlensäureester und neue Copolymere erhältlich aus diesen mehrcyclischen Kohlensäureestern und monocyclischen Carbonaten
EP0139859B1 (de) 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln
CH629769A5 (de) Verfahren zur herstellung von fluorprostaglandinen.
DE2729844C2 (de) Verfahren zur stereoselektiven Herstellung von optisch aktiven 6a,10a-trans-1- Hydroxy-3-alkyl-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo [b,d] pyran-9-onen
EP0112502A2 (de) Omega,omega-Diacyloxy-2,6-dimethyl-octatriensäureester und -aldehyde, Verfahren zu ihrer Herstellung und Verwendung zur Synthese von Terpenverbindungen
DE3590057C1 (de) Verfahren zur Herstellung von Diacyldianhydrohexiten
CH497413A (de) Verfahren zur Herstellung von Acylderivaten des Proscillaridins A
EP0051247B1 (de) 4-Thia- und 4-Sulfinyl-PGI1-Derivate, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende pharmazeutische Präparate
DE3780730T2 (de) Optisch wirksame beta-aminosaeure derivate und ihre salze und verfahren zu deren herstellung.
CH683340A5 (de) Verfahren zur Herstellung von 2,2-Dimethyl-5-(2,5-Dimethylphenoxy)-Pentansäure.
DE1929237A1 (de) Verfahren zur Herstellung von N-Acyl-3,4-epoxy-pyrrolidin-Derivaten
DE3109532C2 (de) Stereoisomere 1,4;3,6-Dianhydro-2,5-diazido-2,5-didesoxyhexite, Verfahren zur Herstellung derselben und diese Verbindungen enthaltende Arzneimittel
DE957123C (de) Verfahren zur Herstellung von Thioabkoemmlingen der Colchiceine
DE1795424B2 (de) Glucuronsaeureester von 1-acyl-2methyl-5-methoxy-3-indolylessigsaeuren
AT288363B (de) Verfahren zur Herstellung von neuen β-Aroyl- β-halogenacrylsäuren
CH635055A5 (de) Verfahren zur herstellung lipidsenkender alkylenglykolderivate.
DE1470196C (de) 1 Hydroxymethyl colchicindenvate und Verfahren zu ihrer Herstellung